The Genetics & Molecular Components of Glioma Patients
WebcastFaculty
OVERVIEW
The Genetics & Molecular Components of Glioma Patients is organized by American Association of Neurological Surgeons (AANS) and would be held during Feb 22, 2016 - Feb 22, 2019. This CME Conference has been approved for a maximum of 0.25 AMA PRA Category 1 Credits.
Conference Objectives are :
• Describe the histological classification of low and high-grad gliomas.
• Describe the role of IDH1, ARTRX, and 1p19q co-deletions, and MGMT and TERT promoter mutations on glioma growth.
• Recognize the significance of common molecular and genetic mutations on glioma response to chemoradiation and prognosis.
Additional details will be posted as soon as they are available.
Conference Objectives are :
• Describe the histological classification of low and high-grad gliomas.
• Describe the role of IDH1, ARTRX, and 1p19q co-deletions, and MGMT and TERT promoter mutations on glioma growth.
• Recognize the significance of common molecular and genetic mutations on glioma response to chemoradiation and prognosis.
Additional details will be posted as soon as they are available.
SPECIALITIES
OncologyGenetics
Quick Links